Found: 36
Select item for more details and to access through your institution.
Letter: Should HBV Therapy Be Stopped Based on HBsAg Level Alone? Authors' Reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 404, doi. 10.1111/apt.18439
- By:
- Publication type:
- Article
Letter: Real‐Life Evaluation of Effectiveness of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease Emphasises Importance of Appropriate Patient Selection and Centre Expertise—Authors' Reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 412, doi. 10.1111/apt.18432
- By:
- Publication type:
- Article
No Association Between Eosinophilic Oesophagitis and Oesophageal Cancer in US Adults: A Case–Control Study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 363, doi. 10.1111/apt.18431
- By:
- Publication type:
- Article
Editorial: Mesenchymal Stem Cell Therapy for Perianal Fistulising Crohn's Disease—Effective or Hype? Authors' Reply.
- Published in:
- 2025
- By:
- Publication type:
- Editorial
Letter: Extending the Measurement of Inflammatory Bowel Disease Severity to Include Patient Important Outcomes—Authors' Reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 408, doi. 10.1111/apt.18421
- By:
- Publication type:
- Article
Clinical Trial: Treatment of Functional Dyspepsia According to Subtype Compared With Empirical Proton Pump Inhibitor.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 258, doi. 10.1111/apt.18418
- By:
- Publication type:
- Article
Letter: Towards Better Intervention Strategies for MASLD and MetALD—What Are We Missing? Authors' Reply.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 400, doi. 10.1111/apt.18412
- By:
- Publication type:
- Article
Letter: Real‐Life Evaluation of Effectiveness of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease Emphasises the Importance of Appropriate Patient Selection and Centre Expertise.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 410, doi. 10.1111/apt.18411
- By:
- Publication type:
- Article
Letter: Extending the Measurement of Inflammatory Bowel Disease Severity to Include Patient Important Outcomes.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 406, doi. 10.1111/apt.18410
- By:
- Publication type:
- Article
Editorial: Mesenchymal Stem Cell Therapy for Perianal Fistulising Crohn's Disease—Effective or Hype?
- Published in:
- 2025
- By:
- Publication type:
- Case Study
Letter: Should HBV Therapy Be Stopped Based on HBsAg Level Alone?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 402, doi. 10.1111/apt.18407
- By:
- Publication type:
- Article
Editorial: Updated COVID‐19 Boosters—Tailoring Protection for Patients With IBD. Authors' Reply.
- Published in:
- 2025
- By:
- Publication type:
- Editorial
Editorial: Rebuilding Rome—Revising Diagnostic Criteria for Irritable Bowel Syndrome.
- Published in:
- 2025
- By:
- Publication type:
- Case Study
Letter: Integrating Psychological Profiles Into Dietary Interventions for IBS—Commentary on HADS Scores and Treatment Efficacy.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 396, doi. 10.1111/apt.18396
- By:
- Publication type:
- Article
Editorial: Assessing the Prognosis of Patients With HBV and ACLF—Comorbidities Matter. Authors' Reply.
- Published in:
- 2025
- By:
- Publication type:
- Editorial
Editorial: Is TIPSS Implantation Effective in Patients With Portal Hypertensive Gastropathy?
- Published in:
- 2025
- By:
- Publication type:
- Editorial
Meta‐Analysis: Prevalence of Frailty and Associated Adverse Events in Inflammatory Bowel Diseases.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 246, doi. 10.1111/apt.18390
- By:
- Publication type:
- Article
Correction to 'Stromal Vascular Fraction With Platelet‐Rich Plasma Injection During Surgery is Feasible and Safe in Treatment‐Refractory Perianal Fistulising Crohn's Disease: A Pilot Study'.
- Published in:
- 2025
- Publication type:
- Correction Notice
Editorial: Understanding Factors Associated With Abdominal Pain in Ulcerative Colitis—No Surprises but the Usual Suspects Need Greater Attention. Authors' Reply.
- Published in:
- 2025
- By:
- Publication type:
- Editorial
Editorial: Updated COVID‐19 Boosters—Tailoring Protection for Patients With IBD.
- Published in:
- 2025
- By:
- Publication type:
- Case Study
Letter: Towards Better Intervention Strategies for MASLD and MetALD—What Are We Missing?
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 398, doi. 10.1111/apt.18375
- By:
- Publication type:
- Article
Editorial: Disentangling Early‐Life Antibiotics and Infections as Risk Factors for the Development of Childhood IBD.
- Published in:
- 2025
- By:
- Publication type:
- Editorial
Letter: Insulin‐Like Growth Factor‐1 in Cirrhosis Is Linked to Hepatic Dysfunction and Fibrogenesis and Predicts Liver‐Related Mortality.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 394, doi. 10.1111/apt.18366
- By:
- Publication type:
- Article
Early‐Life Infections, Antibiotics and Later Risk of Childhood and Early Adult‐Onset Inflammatory Bowel Disease: Pooled Analysis of Two Scandinavian Birth Cohorts.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 323, doi. 10.1111/apt.18358
- By:
- Publication type:
- Article
Portal Hypertensive Gastropathy and MELD‐Na Score Predict Recurrent Gastrointestinal Bleeding After TIPSS: An ALTA Group Study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 346, doi. 10.1111/apt.18362
- By:
- Publication type:
- Article
Editorial: Assessing the Prognosis of Patients With HBV and ACLF—Comorbidities Matter.
- Published in:
- 2025
- By:
- Publication type:
- Editorial
Editorial: Is There a Role for Therapeutic Drug Monitoring of Subcutaneous Infliximab in Patients With Inflammatory Bowel Disease?
- Published in:
- 2025
- By:
- Publication type:
- Editorial
Evaluation of the Effectiveness and Safety of Mesenchymal Stem Cell Treatment in Fistulising Crohn's Disease: An International Real‐Life Retrospective Multicentre Cohort Study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 335, doi. 10.1111/apt.18359
- By:
- Publication type:
- Article
Validating Simple Modifications to the Rome IV Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary Care.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 354, doi. 10.1111/apt.18363
- By:
- Publication type:
- Article
Subcutaneous Infliximab Concentration Thresholds for Mucosal and Transmural Healing in Patients With Crohn's Disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 313, doi. 10.1111/apt.18354
- By:
- Publication type:
- Article
Editorial: Understanding Factors Associated With Abdominal Pain in Ulcerative Colitis—No Surprises But the Usual Suspects Need Greater Attention.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 371, doi. 10.1111/apt.18353
- By:
- Publication type:
- Article
XBB.1.5‐Adapted COVID‐19 mRNA Vaccines but Not Infections With Previous Omicron Variants Boost Neutralisation Against the SARS‐CoV‐2 JN.1 Variant in Patients With Inflammatory Bowel Disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 299, doi. 10.1111/apt.18349
- By:
- Publication type:
- Article
aCCI‐HBV‐ACLF: A Novel Predictive Model for Hepatitis B Virus‐Related Acute‐On‐Chronic Liver Failure.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 286, doi. 10.1111/apt.18347
- By:
- Publication type:
- Article
Prevalence of Low FIB‐4 in MASLD‐Related Hepatocellular Carcinoma: A Multicentre Study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 278, doi. 10.1111/apt.18346
- By:
- Publication type:
- Article
Factors Associated With Abdominal Pain in Patients With Active and Quiescent Ulcerative Colitis: A Multicohort Study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 268, doi. 10.1111/apt.18344
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 2, p. 243, doi. 10.1111/apt.18070
- Publication type:
- Article